首页> 外文期刊>Journal of Medical Virology >Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway
【24h】

Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway

机译:人乳头瘤病毒16型E6癌蛋白通过Toll样受体3信号通路促进非小细胞肺癌细胞的增殖和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Human papillomavirus (HPV) oncoproteins play vital roles in non-small cell lung cancer (NSCLC) pathogenesis, and Toll-like receptors (TLRs) contribute to tumor progression. However, interaction between HPV oncoproteins and TLR signaling in NSCLC progression remains unclear. Thus, the aim of the study was to explore effects of HPV16 E6 oncoprotein-induced TLRs pathway on growth and invasion of NSCLC cells and to examine potential mechanisms being involved. Recombinant plasmid (pcDNA-HPV16 E6) expressing HPV16 E6 protein was constructed. The expression prolife of TLRs was measured in NSCLC cell line A549 with or without pcDNA-HPV16 E6 transfection by real-time reverse polymerase chain reaction and Western blot. Cellular proliferation, invasion, cytokine productions, and downstream signaling pathways were also examined in TLR3-silencing/pcDNA-HPV16 E6 transfect A549 cells. Overexpression of HPV16 E6 increased proliferation, invasion, proliferation cytokine secretion, and TLR3 expression of A549 cells, while TLR3 silence inhibited HPV16 E6-induced tumor bioactivities of A549 cells. Down-regulation of TLR3 suppressed HPV16 E6-induced phosphorylation of Src, but did not affect TRIF expression. Moreover, inhibition of Src pathway also suppressed proliferation and invasion of A549 cells. In conclusion, HPV16 E6 oncoprotein promoted the bioactivities of NSCLC cells. TLR3-Src signaling pathway might be involved in this procession by up-regulation of cytokine production. The interaction between HPV16 E6 protein and TLR3 might contribute to the poor prognosis of NSCLC.
机译:人乳头瘤病毒(HPV)癌蛋白在非小细胞肺癌(NSCLC)发病机制中起重要作用,并且造成的受体(TLR)有助于肿瘤进展。然而,NSCLC进展中HPV癌蛋白和TLR信号传导之间的相互作用仍不清楚。因此,该研究的目的是探讨HPV16 E6癌蛋白诱导的TLRS途径对NSCLC细胞生长和侵袭的影响,并检查所涉及的潜在机制。构建表达HPV16 E6蛋白的重组质粒(PCDNA-HPV16 E6)。通过实时反应聚合酶链反应和Western印迹,在NMSCLC细胞系A549中测量TLR的表达脯氨酸,在NSCLC细胞系A549中测量。在TLR3沉默/ PCDNA-HPV16 E6中还检查了细胞增殖,侵袭,细胞因子制作和下游信号通路。转染A549细胞。 HPV16 E6的过度表达增加了A549细胞的增殖,侵袭,增殖细胞因子分泌和TLR3表达,而TLR3沉默抑制了HPV16 E6诱导的A549细胞肿瘤生物活性。 TLR3的下调抑制了SRC的HPV16 E6诱导的磷酸化,但不影响TRIF表达。此外,SRC途径的抑制还抑制了A549细胞的增殖和侵袭。总之,HPV16 E6癌蛋白促进了NSCLC细胞的生物活性。通过细胞因子生产的上调,可以参与TLR3-SRC信号通路。 HPV16 E6蛋白和TLR3之间的相互作用可能导致NSCLC的不良预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号